These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 24153450)

  • 1. Lung cancer screening: review and performance comparison under different risk scenarios.
    Tota JE; Ramanakumar AV; Franco EL
    Lung; 2014 Feb; 192(1):55-63. PubMed ID: 24153450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of Lung Cancer Screening in Canada.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    JAMA Oncol; 2015 Sep; 1(6):807-13. PubMed ID: 26226181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.
    Mahadevia PJ; Fleisher LA; Frick KD; Eng J; Goodman SN; Powe NR
    JAMA; 2003 Jan; 289(3):313-22. PubMed ID: 12525232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of lung cancer screening with low-dose computed tomography in heavy smokers: a microsimulation modelling study.
    Du Y; Sidorenkov G; Heuvelmans MA; Groen HJM; Vermeulen KM; Greuter MJW; de Bock GH
    Eur J Cancer; 2020 Aug; 135():121-129. PubMed ID: 32563896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
    Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
    CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
    Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
    PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study.
    Kowada A
    BMC Pulm Med; 2022 Jan; 22(1):19. PubMed ID: 34996423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
    Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
    Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relations Between False Positive and Negative Screens and Smoking Cessation and Relapse in the National Lung Screening Trial: Implications for Public Health.
    Clark MA; Gorelick JJ; Sicks JD; Park ER; Graham AL; Abrams DB; Gareen IF
    Nicotine Tob Res; 2016 Jan; 18(1):17-24. PubMed ID: 25746779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
    Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
    J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
    Kumar V; Cohen JT; van Klaveren D; Soeteman DI; Wong JB; Neumann PJ; Kent DM
    Ann Intern Med; 2018 Feb; 168(3):161-169. PubMed ID: 29297005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions.
    Villanti AC; Jiang Y; Abrams DB; Pyenson BS
    PLoS One; 2013; 8(8):e71379. PubMed ID: 23940744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended.
    Faselis C; Nations JA; Morgan CJ; Antevil J; Roseman JM; Zhang S; Fonarow GC; Sheriff HM; Trachiotis GD; Allman RM; Deedwania P; Zeng-Trietler Q; Taub DD; Ahmed AA; Howard G; Ahmed A
    JAMA Oncol; 2022 Oct; 8(10):1428-1437. PubMed ID: 35900734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes and Beliefs of Primary Care Providers in New Mexico About Lung Cancer Screening Using Low-Dose Computed Tomography.
    Hoffman RM; Sussman AL; Getrich CM; Rhyne RL; Crowell RE; Taylor KL; Reifler EJ; Wescott PH; Murrietta AM; Saeed AI; Mishra SI
    Prev Chronic Dis; 2015 Jul; 12():E108. PubMed ID: 26160294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
    JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Perspectives on Low-Dose Computed Tomography for Lung Cancer Screening, New Mexico, 2014.
    Mishra SI; Sussman AL; Murrietta AM; Getrich CM; Rhyne R; Crowell RE; Taylor KL; Reifler EJ; Wescott PH; Saeed AI; Hoffman RM
    Prev Chronic Dis; 2016 Aug; 13():E108. PubMed ID: 27536900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer risk by years since quitting in 30+ pack year smokers.
    Pinsky PF; Zhu CS; Kramer BS
    J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct and indirect healthcare costs of lung cancer CT screening in Denmark: a registry study.
    Jensen MD; Siersma V; Rasmussen JF; Brodersen J
    BMJ Open; 2020 Jan; 10(1):e031768. PubMed ID: 31969362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.